Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations.

Castellan, Pietro; Marchioni, Michele; Castellucci, Roberto; De Francesco, Piergustavo; Iantorno, Romina; Schips, Luigi; Cindolo, Luca.

Afiliação

Castellan P; Department of Urology, ASL02 Abruzzo, Chieti, Italy, castellanpietro@gmail.com.
Marchioni M; Department of Urology, University "G. d'Annunzio", Chieti, Italy.
Castellucci R; Department of Urology, ASL02 Abruzzo, Chieti, Italy, castellanpietro@gmail.com.
De Francesco P; Department of Urology, University "G. d'Annunzio", Chieti, Italy.
Iantorno R; Department of Urology, ASL02 Abruzzo, Chieti, Italy, castellanpietro@gmail.com.
Schips L; Department of Urology, ASL02 Abruzzo, Chieti, Italy, castellanpietro@gmail.com.
Cindolo L; Department of Urology, University "G. d'Annunzio", Chieti, Italy.

Ther Clin Risk Manag ; 14: 2341-2347, 2018.

Article em En | MEDLINE | ID: mdl-30584309